Ligand Pharmaceuticals' Q3 2024 earnings report beat on the top and bottom lines, reinforcing my confidence. Read what makes ...
Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might ...
Upcoming data from a mid-stage study of Amgen's experimental weight-loss drug MariTide will shed light on how well it might ...
The world of pharmacenutical stocks has a lot to offer investors. With their resilience in the face of economic issues and ...
Investors are fearful RFK Jr.'s critical stance on weight loss drugs could impact pricing or Medicare coverage, but BMO says ...
The novel therapy, delivered via implantable, pill-sized device, improved RA signs and symptoms in patients receiving daily ...
A study using a Korean database found that COVID-19 infection raised long-term risks for various autoimmune and ...
Latigo Biotherapeutics ("Latigo"), a clinical-stage biotechnology company developing best-in-class non-opioid pain medicines ...
Amgen Inc. lost requests for several judgments in Lindis Biotech GmbH’s patent-infringement lawsuit seeking damages for sales of the leukemia treatment Blincyto, according to a federal judge’s mixed ...
Howard Chang will take over as chief scientific officer and senior VP of research as the biotech searches for more ways to ...
Kennedy Jr.sharing a McDonald’s meal with Donald Trump aboard Trump Force One may prove to be an early indicator that the ...
With the recent spike in implied volatility, an iron condor on Amgen can use short strikes with a wide profit range.